dr. finn on biomarkers of response in hcc
Published 4 years ago • 108 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
2:09
dr. finn on finding a biomarker for patients with hcc
-
2:56
dr. finn on role of lenvatinib in hcc treatment paradigm
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
7:24
current understanding with biomarkers in hcc
-
2:08
dr. finn on studies of pembrolizumab in hepatocellular carcinoma
-
3:55
liver tumors and liver cancers - the nebraska medical center
-
7:18
liver cancer (hepatocellular carcinoma) and liver transplant | btk/ras-acs journal club #7
-
1:04:49
cancer's hidden networks - dr eric werner fls, university of oxford
-
1:45
dr. finn on current and emerging agents in the field of hcc
-
4:36
biomarkers of response and sequencing for immunotherapy in advanced hcc
-
2:01
immune cell phenotyping and nfl as biomarkers of treatment response in ms
-
1:57
dr. finn on recent advances in the treatment of liver cancer
-
1:34
dr. finn on results of resource study in liver cancer
-
1:38
dr. el-khoueiry discusses research on biomarkers in hcc
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
3:38
biomarkers in liver cancer
-
5:26
hcc whiteboard #1: the epidemiology of hepatocellular carcinoma and current standard of care
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
1:57
dr. kaseb on the progression of hcc research
-
2:14
dr. finn recaps second-line advancements in hcc
-
1:53
dr. do on the assessment of tumor response in liver cancer
-
2:03
dr. finn discusses the pooled analysis of reach and reach-2 in hcc